Text Size

Early Lung Cancer Detection Using Computed Tomography

This study is currently recruiting participants.
Verified February 2012 by University Health Network, Toronto
Sponsor:
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00188734
First received: September 12, 2005
Last updated: February 2, 2012
Last verified: February 2012
History of Changes
  Purpose

Early detection of lung cancer may improve treatment outcomes. Risk factors have been identified, suggesting a population which might benefit from regular screening. Lung cancer screening using low-dose computed tomography (LDCT) has experienced a recent renaissance with reported sensitivity for detection of lung cancer of 2.7% in high-risk populations. The purpose of this study is to evaluate the utility of LCDT for the early diagnosis of lung cancer in Ontario.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lung Cancer Screening in High-risk Smokers Using Low-dose Computed Tomography

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University Health Network, Toronto:

Estimated Enrollment: 5000
Study Start Date: September 2003
  Eligibility

Ages Eligible for Study:   55 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

high risk current and former smokers

Criteria

Inclusion Criteria:

55 years or older at least 10 pack-year history of smoking general good health

Exclusion Criteria:

any prior cancers except non-melanotic skin cancer

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00188734

Contacts
Contact: Heidi C Roberts, MD 416-340-4800 ext 3375 Heidi.Roberts@uhn.on.ca
Contact: Maureen McGregor 416-946-4501 ext 6318 Maureen.mcgregor@uhn.on.ca

Locations
Canada, Ontario
Princess Margaret Hospital Recruiting
Toronto, Ontario, Canada
Contact: Heidi C Roberts, MD     416-340-4800 ext 3375     Heidi.roberts@uhn.on.ca    
Contact: Maureen McGregor     416-946-4501 ext 6318     Maureen.mcgregor@uhn.on.ca    
Principal Investigator: Heidi C Roberts, MD            
Sponsors and Collaborators
University Health Network, Toronto
Investigators
Principal Investigator: Heidi C Roberts, MD University Health Network, Toronto
  More Information

Additional Information:
Related Info  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: UHN Toronto
ClinicalTrials.gov Identifier: NCT00188734     History of Changes
Other Study ID Numbers: I-ELCAP
Study First Received: September 12, 2005
Last Updated: February 2, 2012
Health Authority: Canada: Health Canada

Keywords provided by University Health Network, Toronto:
Lung Cancer
Eary Diagnosis
Screening

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
 Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 21, 2013